Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases

  • Lynn Friedman

Press/Media

Period22 Mar 2017

Media coverage

13

Media coverage